Results 181 to 184 of about 9,340 (184)

Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial

Lancet Respiratory Medicine,the, 2017
Frank C Albers, Linda M Nelsen, Jennifer L Trevor   +2 more
exaly  

Mepolizumab

Reactions Weekly, 2017
openaire   +2 more sources

Anti‐IL‐5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis

Allergy: European Journal of Allergy and Clinical Immunology, 2005
exaly  

Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients

Allergy: European Journal of Allergy and Clinical Immunology
Dennis Thomas, Mark Hew, Sandra Hodge
exaly